Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Razoxane is used as an antimitotic agent with immunosuppressive properties.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 157.00 | |
5 mg | In stock | $ 317.00 | |
10 mg | In stock | $ 447.00 | |
25 mg | In stock | $ 738.00 | |
50 mg | In stock | $ 987.00 | |
100 mg | In stock | $ 1,380.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 287.00 |
Description | Razoxane is used as an antimitotic agent with immunosuppressive properties. |
In vivo | This tumor model is characterized by osteoid formation and spontaneous metastasization to lungs, kidneys and lymph nodes. Razoxane given intraperitoneally (i.p.) from 2 days before to 14 days after tumor transplantation (30 mg/kg or 10 mg/kg per day) resulted in a dose-dependent prolongation of median survival time (83 or 48 days respectively, versus 38 days for the control group), but showed no influence on the growth of the primary tumor. Early treatment with razoxane (30 mg/kg i.p. from day -2 to +14) showed a greater inhibition of pulmonary metastases than later treatment (30 mg/kg i.p. from day +14 to +28 after transplantation). Whereas 59.9 per cent of the total sectional area of the lungs in the control animals was covered by osteosarcoma metastases, only 3.4 per cent and 26.1 per cent respectively was affected in the early and late razoxane treatment groups. Toxic side-effects of these treatment schedules were reversible diffuse alopecia, but no retardation of body weight gain[2]. |
Molecular Weight | 268.27 |
Formula | C11H16N4O4 |
CAS No. | 21416-67-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/ml (223.66 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Razoxane 21416-67-1 DNA Damage/DNA Repair Topoisomerase ICRF 159 ICRF159 ICRF-159 Topoisomerase II Inhibitor RCC Inhibitor renal cell carcinoma inhibit inhibitor